Australia markets close in 2 hours 7 minutes

PolyPeptide Group AG (PPGN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
33.00+1.05 (+3.29%)
At close: 05:30PM CEST
Currency in CHF

Valuation measures4

Market cap (intra-day) 1.05B
Enterprise value 1.07B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.32
Price/book (mrq)2.79
Enterprise value/revenue 3.38
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 338.42%
S&P500 52-week change 326.14%
52-week high 334.60
52-week low 314.11
50-day moving average 329.36
200-day moving average 320.94

Share statistics

Avg vol (3-month) 363.02k
Avg vol (10-day) 329.85k
Shares outstanding 532.97M
Implied shares outstanding 632.97M
Float 812.93M
% held by insiders 160.41%
% held by institutions 122.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 302 May 2022
Ex-dividend date 428 Apr 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -16.06%
Operating margin (ttm)-5.76%

Management effectiveness

Return on assets (ttm)-3.34%
Return on equity (ttm)-12.81%

Income statement

Revenue (ttm)320.37M
Revenue per share (ttm)9.73
Quarterly revenue growth (yoy)28.00%
Gross profit (ttm)N/A
EBITDA -12.31M
Net income avi to common (ttm)-51.44M
Diluted EPS (ttm)-1.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)95.71M
Total cash per share (mrq)2.9
Total debt (mrq)124.78M
Total debt/equity (mrq)32.73%
Current ratio (mrq)1.85
Book value per share (mrq)11.56

Cash flow statement

Operating cash flow (ttm)36.48M
Levered free cash flow (ttm)-31.48M